• 제목/요약/키워드: composite antibiotic

검색결과 21건 처리시간 0.02초

Effect of Prenatal Antibiotic Exposure on Neonatal Outcomes of Preterm Infants

  • Kim, Hyunjoo;Choe, Young June;Cho, Hannah;Heo, Ju Sun
    • Pediatric Infection and Vaccine
    • /
    • 제28권3호
    • /
    • pp.149-159
    • /
    • 2021
  • 목적: 산모의 산전 항생제 사용은 여러가지 면에서 태아 및 신생아에 영향을 미칠 수 있다. 본 연구에서는 극소 미숙아 또는 극소 저체중출생아에서 산모의 산전 항생제 투여 기간이 신생아 예후에 미치는 영향에 대해 조사하였다. 방법: 2015년 9월부터 2020년 12월까지 고려대학교 안암병원에서 출생한 재태주수 32주 미만 또는 출생 체중 1,500 gram 미만인 신생아 및 산모를 대상으로 의무기록을 후향적으로 분석하였다. 산모의 산전 항생제 투여 기간에 따라 미투여 군, 7일 이하 군, 7일 초과 군의 세 군으로 나누어 산모의 특성, 환아의 특성 및 합병증 등을 비교 분석하였다. 결과: 총 145명 중 93명의 환아가 산전 항생제에 노출되었으며, 그 중 35명(37.6%)는 7일 이하 군, 58명(62.4%)는 7일 초과 군이었다. 7일 초과 군은 미투여 군에 비해 재태 연령에 따른 출생체중의 Z-score가 교란변수 보정 후에도 유의미하게 높았다(beta, 0.258; standard error, 0.149; P<0.001). 다변량 로지스틱 회귀 분석에서 7일 초과 군은 사망(adjusted odds ratio [aOR], 8.926; 95% confidence interval [CI], 1.482-53.775), 그리고 사망, 괴사성 장염, 후기 패혈증의 복합 평가 결과와 연관이 있었다(aOR, 2.375; 95% CI, 1.027-5.492). 결론: 산모의 장기간 산전 항생제 투여는, 극소 미숙아 또는 극소 저체중출생아에서 재태 연령에 따른 출생체중의 Z score을 증가시키며, 사망 뿐 아니라 사망, 괴사성 장염, 후기 패혈증의 복합 평가 결과의 위험도를 증가시킬 수 있다.

복합항생제 SM-101(설박탐.메탐피실린)의 생식독성연구: 랫트 수태능력시험 (Reproductive Toxicity Study of SM-101(sulbactam.metampicillin): Fertility Study in Rats)

  • 정문구;송시환;노정구
    • Biomolecules & Therapeutics
    • /
    • 제4권1호
    • /
    • pp.51-58
    • /
    • 1996
  • A new composite antibiotic, SM-101(sulbactam.metampicillin), was at dose levels of 0, 250, 500 and 1000 mg/kg/day administered intravenously to Sprague-Dawley male rats from predating to mating period and to females from premating to early gestation period. Effects of test agent on general findings and reproductive performance of parent animals and embryonic development were examined. In male parents, two deaths occurred at 1000 mg/kg. The increase in kidney weight of the 1000 mg/kg group were also observed. The decrease in body weight and food consumption were found at 500 and 1000 mg/kg. The decrease in spleen weight were seen at 250, 500 and 1000 mg/kg. In female parents, three deaths were found at 1000 mg/kg. Mating performance and fertility of parent animals were not adversely affected by all doses tested. F1 fetuses showed no changes related to treatment of SM-101. The results show that the no effect dose level(NOEL) for general toxicity of parent animals is under 250 mg/kg/day and NOELS for reproductive capability and fatal development are over 1000 mg/kg/day.

  • PDF

복합항생제 SM-101(설박탐.메탐피실린)의 생식독성연구: 랫트 최기형시험 (Reproductive Toxicity Study of SM-101(sulbactam.metampicillin): Teratogenicity Study in Rats)

  • 정문구;김종춘;한상섭
    • Biomolecules & Therapeutics
    • /
    • 제4권1호
    • /
    • pp.59-67
    • /
    • 1996
  • A new composite antibiotic, SM-101(sulbactam·metampicillin), was at dose levels of 0, 375, 750 and 1500 mg/kg/day administered intravenously to pregnant Sprague-Dawley rats during the organogenetic period. Two-third of dams per group were subjected to caesarean section on day 20 of pregnancy and the remaining 10 dams per group were allowed to deliver. Effects of test substance on dams, embryonal development of F1 fetuses, as well as growth, behaviour and mating performance of F1 offspring were examined. In dams, two deaths occurred at 375 and 1500 mg/kg, respectively. The decrease in the weight of adrenal glands of the 1500 mg/kg group was observed. The prolongation of pregnancy period was found at 1500 mg/kg. F1 fetuses showed no changes related to the treatment of SM-101. In F1 offspring, the increase in spleen weight was seen at all doses treated. No treatment-related abnormalities were observed in each treated group in terms of development, behaviour and reproductive performance. In F2 fetuses, no drug-induced abnormalities occurred at all doses. The results show that the no-effect dose levels (NOELS) for dams and Fl offspring are under 375 mg/kg/day and NOELs for F1/F2 fetuses are over 1500 mg/kg/day.

  • PDF

복합항생제 SM-101(설박탐-메탐피실린)의 생식독성연구: 랫트 주산기 및 수유기시험 (Reproductive Toxicity of SM-101(sulbactam.metampicillin): Peri- and Postnatal Study in Rats)

  • 정문구;김종춘;노정구
    • Biomolecules & Therapeutics
    • /
    • 제4권4호
    • /
    • pp.339-348
    • /
    • 1996
  • A new composite antibiotic, SM-101 (sulbactam·metampicillin), was at dose levels of 0, 250, 500 and 1000 mg/kg/day administered intravenously to pregnant and subsequently delivered Sprague-Dawley rats from day 17 of gestation to day 21 of lactation. Effects of test agent on dams and growth, behaviour and mating performance of Fl offspring were examined. In dams, one death occurred at 1000 mg/kg. The increase in kidney weight of the 250, 500 and 1000 mg/kg group was found. In F1 offspring, both delayed incisors eruption and decreased body weight were observed in females of the 1000 mg/kg group. The increase in the weights of liver and kidney was found in males of the 1000 mg/kg group. No treatment-related abnormalities were observed in each treated group in terms of behaviour and reproductive performance. In F1/F2 fetuses, no drug-induced abnormalities occurred at all doses tested. The results show that the no effect dose level (NOEL) of SM-101 is under 250 mg/kg/day for dams and 500 mg/kg/day for F1 offspring, and over 1000 mg/kg/day for F1/F2 fetuses.

  • PDF

항생제-스멕타이트 복합물 유도 및 소화기계 약물전달체로의 가능성 (Development of Antibiotic-intercalated Smectite Composites and Its Drug Delivery Potential in Gastric System)

  • 송윤구;정동훈;송영구;최우현
    • 자원환경지질
    • /
    • 제48권3호
    • /
    • pp.199-204
    • /
    • 2015
  • 본 연구에서는 흡수성 항생제인 Amoxicillin과 Clarithromycin, 그리고 아미노글루코사이드 (Aminoglucoside) 계열 비흡수성 항생제인 Gentamicin, Tobramycin 및 Netilmicin의 스멕타이트 층간 유도를 통해 항생제-스멕타이트 복합물을 합성하고, 이 중 Clarithromycin-스멕타이트 복합물 대상 예비 용출실험을 통해 소화기계 항생제 약물전달체로의 가능성을 확인하고자 하였다. 실험 결과, 5종의 항생제 모두 수용액 상태에서의 교환반을을 통해 스멕타이트 층간에 유도되었다. Clarithromycin에 대하여 스멕타이트 층간 최대 유도 량을 결정하기 위한 농도별 평형반응실험 결과 Langmuir isotherm을 따르며, 층간 최대유도 량은 1.811 mmole/g으로 계산되었다. Clarithromycin-스멕타이트 복합물 대상 pH=2, 3 및 4 용출용액을 이용한 예비 용출실험결과 모든 용출용액에서 지속적인 용출이 일어났으며, pH 증가에 따라 용출량은 감소하였다.

Elution of amikacin and vancomycin from a calcium sulfate/chitosan bone scaffold

  • Doty, Heather A.;Courtney, Harry S.;Jennings, Jessica A.;Haggard, Warren O.;Bumgardner, Joel D.
    • Biomaterials and Biomechanics in Bioengineering
    • /
    • 제2권3호
    • /
    • pp.159-172
    • /
    • 2015
  • Treatment of polymicrobial infected musculoskeletal defects continues to be a challenge in orthopaedics. This research investigated single and dual-delivery of two antibiotics, vancomycin and amikacin, targeting different classes of microorganism from a biodegradable calcium sulfate-chitosan-nHA microsphere composite scaffold. The addition of chitosan-nHA was included to provide additional structure for cellular attachment and as a secondary drug-loading device. All scaffolds exhibited an initial burst of antibiotics, but groups containing chitosan reduced the burst for amikacin at 1hr by 50%, and vancomycin by 14-25% over the first 2 days. Extended elution was present in groups containing chitosan; amikacin was above MIC ($2-4{\mu}g/mL$, Pseudomonas aeruginosa) for 7-42 days and vancomycin was above MIC ($0.5-1{\mu}g/mL$ Staphylococcus aureus) for 42 days. The antibiotic activity of the eluates was tested against S. aureus and P. aeruginosa. The elution from the dual-loaded scaffold was most effective against S. aureus (bacteriostatic 34 days and bactericidal 27 days), compared to vancomycin-loaded scaffolds (bacteriostatic and bactericidal 14 days). The dual- and amikacin-loaded scaffolds were effective against P. aeruginosa, but eluates exhibited very short antibacterial properties; only 24 hours bacteriostatic and 1-5 hours bactericidal activity. For all groups, vancomycin recovery was near 100% whereas the amikacin recovery was 41%. In conclusion, in the presence of chitosan-nHA microspheres, the dual-antibiotic loaded scaffold was able to sustain an extended vancomycin elution longer than individually loaded scaffolds. The composite scaffold shows promise as a dual-drug delivery system for infected orthopaedic wounds and overcomes some deficits of other dual-delivery systems by extending the antibiotic release.

공침법을 이용한 은-수산화아파타이트 항균소재의 제조 (Synthesis of Ag-Hydroxyapatite Antibiotic Material by Coprecipitation Method)

  • 장광규;신헌용
    • Korean Chemical Engineering Research
    • /
    • 제45권5호
    • /
    • pp.473-478
    • /
    • 2007
  • 공침법을 이용하여 질산은($AgNO_3$)을 수산화아파타이트(hydroxyapatite)에 흡착시켜 복합항균제를 제조하였다. 질산은의 농도, 온도, 압력, 숙성시간에 따른 흡착된 은이온양의 변화를 관찰하였고, 은-수산화아파타이트 흡착의 최적조건을 얻었다. 제조된 은-수산화아파타이트를 ICP-MS, SEM-EDAX, DSC, XRD를 이용하여 물리적 화학적 특성을 고찰하였다. 또한 제조된 은-수산화아파타이트는 진탕플라스크실험법(shake flask method, KS M-146-2003)을 이용하여 양성균인 황색포도상구균(staphylococcus aureus, ATCC 6538)과 음성균인 대장균(escherichia coli, ATCC 25922)의 항균성을 확인하였다.

Preparation, Characterization of activated carbon fiber (ACF) from loofah and its application in composite vertical flow constructed wetlands for Tetracycline removal from water

  • Ahmed, Sanjrani Manzoor;Zhou, Boxun;Wang, Yue;Yang, Hang;Zheng, You P.;ShiBin, Xia
    • Membrane and Water Treatment
    • /
    • 제11권4호
    • /
    • pp.313-321
    • /
    • 2020
  • ACF preparation from different materials and its application in constructed wetlands for wastewater treatment has been focused in environmental field. Different materials have been used to prepare ACF around the world. This study aims to prepare, characterize and use of ACF from loofah for removal of Tetracycline from water through composite vertical flow constructed wetlands. ACF was prepared and it was tested for characterization, later it was used for removal of Tetracycline from water through composite vertical flow constructed wetlands. In composite vertical flow constructed wetlands, three HRTs were set according to the experiment, 1D, 2D, and 3D is individually. Samples were transported immediately from collection point to laboratory for analyzing. Samples were measured for Tetracycline (TC), Total Phosphorus (TP), and Total nitrogen and COD. Tetracycline absorbance with respective 356nm was obtained good and HRT is important factor. Results show that composite vertical flow constructed wetlands with ACF from luffa is best option and it is recommended to study further deep analysis.

Revitalization of necrotic mature permanent incisors with apical periodontitis: a case report

  • Nagas, Emre;Uyanik, M. Ozgur;Cehreli, Zafer C.
    • Restorative Dentistry and Endodontics
    • /
    • 제43권3호
    • /
    • pp.31.1-31.7
    • /
    • 2018
  • Despite considerable focus on the regenerative endodontic treatment of immature teeth with necrotic infected pulps and apical periodontitis, little data exist with regard to its possible implementation in necrotic permanent teeth with complete apical and radicular development. The present report describes the procedures and outcome of a regenerative endodontic treatment approach in 2 previously-traumatized incisors with closed apex with apical periodontitis. A 2-visit treatment procedure was employed. At initial visit, the root canals were copiously irrigated, followed by placement of a triple antibiotic paste containing ciprofloxacin, metronidazole, and clindamycin into the root canals. After 4 weeks, the antibiotic paste was removed, and apical bleeding was initiated with size 10 hand files beyond the apices. The root canals were coronally sealed with mineral trioxide aggregate, and the access cavities were restored with bonded resin composite. At post-operative 60 months, both teeth were remained asymptomatic, with the recall radiographs showing complete resolution of apical radiolucency and reestablishment of periradicular tissues. In both teeth, the dimensions of root space remained unchanged as verified by image analysis. The revitalization protocol utilizing root canal disinfection and induced apical bleeding in necrotic, closed-apex incisors may offer a clinically acceptable alternative to conventional root canal treatment.

쥐하지부 동종이식에서 FK-506과 Rapamycin을 사용하여 이식부 생존기간에 대한 효과의 비교관찰 (Efficacy of FK-506 and Rapamycin in Prolongation of Allograft Rat Limb Survival)

  • 서인석
    • Archives of Reconstructive Microsurgery
    • /
    • 제4권1호
    • /
    • pp.9-15
    • /
    • 1995
  • Free vascularized composite tissue transfer is more frequently underwent for reconstruction of complicated tissue defects with the recent advance of microsurgery. But postoperative result was not satifactory because of donor site morbidity, flap bulkiness and cosmetic problem. So would no longer be a problem if we can obtain the exact donor tissue required for the recipient site as allotransplantation and designing the flap. Allotransplantation has been resolved with the recent development of immunosuppressive agents, while reconstruction has made great progress with the refinement of microsurgical techniques in the last 20 years. The final sucess or failure of the operative procedure in transplantation is so utterly dependent no the availability of strategies that can control the immune system effectively, selectively, safely to allow allotransplantation of a nonvital body part. 1 used 2 strains of rats, BUF and LEW, for the limb allotransplantation as a composite tissue transfer. The primary goal of this program is to improve results in clinical transplantation by accelerating the transformation of new immunological knowledge into useful medicine. Two of the most promising new immunosuppressive compounds are FK-t06(FK) and rapamycin(RPM). Both drugs are antibiotic macrolide fungal fermentation products that presumably suppress the immune system in ways similar to cyclosporin(CyA). This study shows that two new immunosuppressive drugs compare the immunosuppressive activity and effectiveness of FK-506 and RPM for prevention of the limb allograft rejection in the rat. Additional experiments investigate the dose, route of administration and histologic findings. These data demonstrates that rapamycin is far more potent and effective than FK-506 when both compounds are administered by the intraperitoneal route, as well as prolonged graft survival significantly in a dose-route dependent manner. These results lead to the view that vascularized allograft composite tissue transfer can become a reality with the expectation of possible future application in reconstructive surgery of humans.

  • PDF